BIOMAT Database Logo BIOMAT Database Logo

Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. 1994

B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Department of Radiology, University of California, San Francisco 94143-0628.

OBJECTIVE To evaluate the accuracy of contrast material-enhanced computed tomography (CT), unenhanced T1- and T2-weighted magnetic resonance (MR) imaging, and dynamic gadolinium-enhanced spoiled gradient-echo MR imaging in the staging of bladder cancer. METHODS Thirty-six patients with histologically proved bladder cancer were prospectively examined with CT and MR imaging before tumor resection. Images were evaluated in a blinded fashion. RESULTS All methods depicted tumors comparably well. Staging was correct in 16 of 29 patients (55%) with CT and 27 of 36 patients (75%) overall with MR imaging. Overstaging was the most common error, and both CT and MR imaging were more accurate for higher-staged tumors. CONCLUSIONS CT and MR imaging perform well in the detection of tumors but are less accurate in staging. Dynamic gadolinium-enhanced MR imaging is better than other techniques, but the difference is not statistically significant.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008536 Meglumine 1-Deoxy-1-(methylamino)-D-glucitol. A derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. Often used in conjunction with iodinated organic compounds as contrast medium. Methylglucamine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009942 Organometallic Compounds A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed) Metallo-Organic Compound,Metallo-Organic Compounds,Metalloorganic Compound,Organometallic Compound,Metalloorganic Compounds,Compound, Metallo-Organic,Compound, Metalloorganic,Compound, Organometallic,Compounds, Metallo-Organic,Compounds, Metalloorganic,Compounds, Organometallic,Metallo Organic Compound,Metallo Organic Compounds
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm

Related Publications

B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
December 1992, Radiology,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging with fat-suppressed T2-weighted, breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences.
January 1994, Journal of magnetic resonance imaging : JMRI,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging.
January 1999, Radiographics : a review publication of the Radiological Society of North America, Inc,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Acute myocardial infarction: comparison of T2-weighted and T1-weighted gadolinium-DTPA enhanced MR imaging.
February 1991, Magnetic resonance in medicine,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T.
September 1992, Radiology,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Comparison of T2-weighted imaging, diffusion-weighted imaging and contrast-enhanced T1-weighted MR imaging for evaluating perianal fistulas.
January 2017, Clinical imaging,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
June 1999, Radiology,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
August 2000, Radiology,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
July 2006, Radiology,
B Kim, and R C Semelka, and S M Ascher, and D B Chalpin, and P R Carroll, and H Hricak
Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.
March 2002, AJNR. American journal of neuroradiology,
Copied contents to your clipboard!